1. Home
  2. ALUR vs VVOS Comparison

ALUR vs VVOS Comparison

Compare ALUR & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALUR
  • VVOS
  • Stock Information
  • Founded
  • ALUR 2009
  • VVOS 2016
  • Country
  • ALUR United States
  • VVOS United States
  • Employees
  • ALUR N/A
  • VVOS N/A
  • Industry
  • ALUR
  • VVOS Medical Specialities
  • Sector
  • ALUR
  • VVOS Health Care
  • Exchange
  • ALUR Nasdaq
  • VVOS Nasdaq
  • Market Cap
  • ALUR 19.1M
  • VVOS 18.5M
  • IPO Year
  • ALUR N/A
  • VVOS 2020
  • Fundamental
  • Price
  • ALUR $3.10
  • VVOS $2.57
  • Analyst Decision
  • ALUR Strong Buy
  • VVOS Strong Buy
  • Analyst Count
  • ALUR 3
  • VVOS 2
  • Target Price
  • ALUR $22.83
  • VVOS $6.30
  • AVG Volume (30 Days)
  • ALUR 4.1M
  • VVOS 83.4K
  • Earning Date
  • ALUR 05-13-2025
  • VVOS 03-31-2025
  • Dividend Yield
  • ALUR N/A
  • VVOS N/A
  • EPS Growth
  • ALUR N/A
  • VVOS N/A
  • EPS
  • ALUR N/A
  • VVOS N/A
  • Revenue
  • ALUR $32,110,000.00
  • VVOS $15,031,000.00
  • Revenue This Year
  • ALUR N/A
  • VVOS $12.35
  • Revenue Next Year
  • ALUR $38.86
  • VVOS $26.02
  • P/E Ratio
  • ALUR N/A
  • VVOS N/A
  • Revenue Growth
  • ALUR N/A
  • VVOS 8.91
  • 52 Week Low
  • ALUR $2.15
  • VVOS $1.91
  • 52 Week High
  • ALUR $98.75
  • VVOS $6.28
  • Technical
  • Relative Strength Index (RSI)
  • ALUR 46.93
  • VVOS 30.17
  • Support Level
  • ALUR $2.72
  • VVOS $2.38
  • Resistance Level
  • ALUR $3.45
  • VVOS $3.36
  • Average True Range (ATR)
  • ALUR 0.41
  • VVOS 0.30
  • MACD
  • ALUR 0.15
  • VVOS -0.08
  • Stochastic Oscillator
  • ALUR 44.04
  • VVOS 13.30

About ALUR Allurion Technologies Inc.

Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: